drugset / Trial / NCT01607112
A Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to assess the immunogenicity and safety of GSK Biologicals' trivalent influenza vaccine manufactured for the 2012/2013 influenza season administered in adults (18 to 60 years) and in elderly (over 60 years).
Timeline
- Start
- 2012-07-10
- Primary completion
- 2012-07-31
- Completion
- 2012-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluarix/Influsplit SSW 2012-2013 | Vaccine | — | Intramuscular |